Fatality resulting from intraventricular vincristine administration

Journal of Toxicology - Clinical Toxicology

Volumn 36, Issue 3, 1998, Pages 243-246

  Meggs, William J ^a,b   Hoffman, Robert S ^a  

^a NEW YORK CITY POISON CONTROL CENTER   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DAUNORUBICIN; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID FLOW; COMA; DIALYSIS; DISORIENTATION; DRUG DELIVERY SYSTEM; FATALITY; FEMALE; HUMAN; IATROGENIC DISEASE; INTOXICATION; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NAUSEA; NYSTAGMUS; RESERVOIR; STUPOR; TREMOR; VOMITING;

ARA; POMACANTHUS MACULOSUS;

EID: 0031842847     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.3109/15563659809028947     Document Type: Article

References (15)

1. De Vita VT Jr. Consequences of the chemotherapy of Hodgkin's disease: The 10th David A. Karnofsky memorial lecture. Cancer 1981;47:1-13.
2. Calabresi P, Schein PS, Rosenberg SA, eds. Medical Oncology: Basic Principles and Clinical Management of Cancer. New York: Macmillan, 1985.
3. Slyter H, Liwnicz B, Herrick MK, Mason R. Fatal myeloencephalopathy caused by intrathecal vincristine. Neurology 1980;30:867-871.
4. Williams ME, Walker AN, Bracikowski JP, Garner L, Wilson KD, Carpenter JT. Ascending myeloencephalopathy due to intrathecal vincristine sulfate. A fatal chemotherapeutic error. Cancer 1983;51: 2041-2047.
5. Schochet SS Jr, Lampert PW, Earle KM. Neuronal changes induced by intrathecal vincristine sulfate. J Neuropathol Exp Neurol 1968;27:645-658.
6. Shepherd, DA, Steuber CP, Starling KA, Fernbach DJ. Accidental intrathecal administration of vincristine. Med Pediatr Oncol 1978;5:85-88.
7. Manelis J, Freudlich E, Ezekiel E, Doron J. Accidental intrathecal vincristine administration: Report of a case. J Neurol 1982;228:209-213.
8. Dyke RW. Treatment of inadvertent intrathecal injection of vincristine. N Engl J Med 1989;321: 1270-1271.
9. Gaidys WG, Dickerman JD, Walters CL, Young PC. Intrathecal vincristine: Report of a fatal case despite CNS washout. Cancer 1983;52:799-801.
10. Al Fawaz IM. Fatal myeloencephalopathy due to intrathecal vincristine administration. Ann Trop Paediatr 1992;12:339-342.
11. Bain PG, Lantos PL, Djurovic V, West I. Intrathecal incristine: A fatal chemotherapeutic error with devastating central nervous system effects. J Neurol 1991;238:230-234.
12. Bleck TP, Jacobsen J. Prolonged survival following the inadvertent intrathecal administration of vincristine: Clinical and electrophysiologic analyses. Clin Neuropharmacol 1991;14:457-462.
13. Zaragoza MR, Ritchey ML, Walter A. Neurologic consequences of accidental intrathecal vincristine: A case report. Med Pediatr Oncol 1995;24:61-62.
14. Lau G. Accidental intraventricular vincristine administration: An avoidable iatrogenic death. Med Sci Law 1996;36:263-265.
15. Jackson DV, Wells HB, Atkins JN, et al. Amelioration of vincristine neurotoxicity by glutamic acid. Am J Med 1988;84:1016-1022.